Despite significant dips in its vaccines sales, the British pharma narrowly beat consensus estimates for Q4 2024 and raised ...

We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

Its cash, cash equivalents, and short-term marketable securities balance was around $1.2 billion in 2022, and we expect the trend of no/low debt and deep pockets of cash to continue over the next five ...

Two members of Connecticut’s congressional delegation said they hope President Donald Trump will rethink his proposed tariffs before they “leave massive wounds on our economy.” ...

Hamlet” (the original) was written, of course, in 1600s vintage English blank verse; much of “Fat Ham” is in Black English ...

Operator Good morning, and welcome to the Johnson Controls first-quarter 2025 earnings conference call. [Operator ...

Homelessness is at a record high, and there are many investigative stories to tell. ProPublica compiled some of the tips and lessons its reporters learned.

Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Good day, and welcome to the Centene Corporation Fourth Quarter ...

The last few days have been a rollercoaster for the pharmaceutical industry. Mexico and Canada were bracing themselves for ...

Six years after an Iowa City physician allegedly failed to properly prescribe medications to patients, the state Board of Medicine has placed her license on probation.

Q2 2025 Earnings Conference Call February 5, 2025 5:00 PM ETCompany ParticipantsMichael Florin - Senior Vice President ...